Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371993 · ClinicalTrials.gov registry record · Phase 3
Asthma in the Elderly: A Study of Choline Supplementation
A Phase 3 study, sponsored by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C..
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT02371993: Completed Phase 3 study, sponsored by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C..
NCT02371993 is a Phase 3 study that has completed, run by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02371993, a Phase 3 study, has completed, sponsored by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
Asthma in the elderly is poorly understood, as most studies have not included this patient group. In a previous study of adults with asthma, choline supplementation had a positive effect on asthma symptoms and allowed to decrease asthma pharmacologic treatment. The present study is a randomized, double-blind, placebo-controlled, cross-over study of choline supplementation. The investigators will study the effect of choline 650 mg taken orally twice daily x 6 weeks versus placebo on asthma symptom scores (Asthma Control Test) and spirometric values (FEV1, FEV1/FVC, FEF25-75%). The investigators will also look at the effect of choline supplementation on peripheral blood eosinophils, serum immunoglobulin E (IgE) and homocysteine levels.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Choline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371993
The ClinicalTrials.gov registry entry for NCT02371993 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C., which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02371993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02371993 about?
NCT02371993 is a clinical study titled "Asthma in the Elderly: A Study of Choline Supplementation". Asthma in the elderly is poorly understood, as most studies have not included this patient group. In a previous study of adults with asthma, choline supplementation had a positive effect on asthma symptoms and allowed to decrease asthma pharmacologic treatment. The present study is a randomized, dou...
What is the current status of trial NCT02371993?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2015-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02371993?
The interventions under investigation include: Placebo (OTHER), Choline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02371993?
This trial is sponsored by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.